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AbstrACt
Objective To user-test a web-based, interactive Option 
Grid decision aid ‘prostate-specific antigen (PSA) test: 
yes or no?’ to determine its usability, acceptability and 
feasibility with men of high and low health literacy.
Design A semi-structured interview study.
setting Interviews were conducted at a senior centre, 
academic hospital or college library in New Hampshire and 
Vermont.
Participants Individuals over 45 years of age with no 
history of prostate cancer who voluntarily contacted 
study authors after viewing local invitations were eligible 
for inclusion. Twenty interviews were conducted: 10 
participants had not completed a college degree, of which 
eight had low health literacy, and 10 participants had high 
health literacy.
Intervention An interactive, web-based Option Grid 
patient decision aid for considering whether or not to have 
a PSA test.
results Users with lower health literacy levels were able 
to understand the content in the tool but were not able 
to navigate the Option Grid independent of assistance. 
The tool was used independently by men with high health 
literacy. In terms of acceptability, the flow of questions and 
answers embedded in the tool did not seem intuitive to 
some users who preferred seeing more risk information 
related to age and family history. Users envisioned that the 
tool could be feasibly implemented in clinical workflows.
Conclusion Men in our sample with limited health literacy 
had difficulty navigating the Option Grid, thus suggesting 
that the tool was not appropriately designed to be usable 
by all audiences. The information provided in the tool is 
acceptable, but users preferred to view personalised risk 
information. Some participants could envision using this 
tool prior to an encounter in order to facilitate a better 
dialogue with their clinician.
Ethics approval The study received ethical approval from 
the Dartmouth College Committee for the Protection of 
Human Subjects (STUDY00030116).
bACkgrOunD
A growing number of developers are creating 
web-based, interactive decision aids and this 
includes tools for men considering the pros-
tate-specific antigen (PSA) test.1 Patient deci-
sion aids are designed to provide users with 
evidence-based information on a particular 
health condition or screening test, and many 
men are using these tools when needing to 
make a preference sensitive decision – such as 
whether they should have a PSA test. Part of 
the development process is to user-test these 
web-based PSA decision aids to ensure they are 
easy to use and meet the needs and desires of 
men.2–4 
The International Patient Decision Aid Stan-
dards indicate that users should be involved in 
the development process of these interventions.2 
Elwyn et al proposed a four-step process map for 
developing web-based tools which recommends 
usability testing and field testing.3 Once a proto-
type is deemed ready by developers, it should be 
user-tested by stakeholders, including patients, 
to provide their perspective on elements of the 
tool that need to be improved (ie, navigation 
and design). This is a key step in the process 
prior to introducing the web-based decision 
aid in clinical settings for further evaluation.3 
A review conducted by Coulter et al outlined 
similar processes to evaluate patient decision 
aids all of which recommend user-testing or 
strengths and limitations of this study
 ► The strength of this study was the use of the think-
aloud technique in conjunction with in-depth inter-
views to examine the usability, acceptability and 
feasibility of the Option Grid.
 ► The sample includes participants with lower lev-
els of health literacy and education who are not 
computer-savvy.
 ► Due to two study authors’ (GE and M-AD) involve-
ment in developing the prostate-specific antigen 
interactive Option Grid, PS conducted the interviews 
and analysis of the data to mitigate the risk of bias.
 ► A weakness of our study is the fact that we did not 
use a validated framework to user-test patient de-
cision aids.
 ► We recognise that including a more diverse sam-
ple of men (ie, ethnicity and geographical location) 
could have provided us with a different user-testing 
perspective.
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determining the needs of patients who will eventually use 
these tools.4 The Ottawa Decision Support Framework, for 
example, described an iterative process to decision aid devel-
opment which includes ‘assessment of determinants of deci-
sions’ through the lens of the patient and provider.4 5 Patient 
input enables developers to create robust tools that are 
acceptable to potential users while addressing their needs 
and concerns.6 However, involving patients is time-con-
suming and costly.4 Many developers bypass the user-testing 
step and post tools that may not be suitable for the target 
audience.
According to a recent explanatory study by Dugas et al, 
of the patient decision aid development projects that have 
been conducted, less than 20 per cent include vulnerable 
populations (ie, patients with low health literacy).7 Health 
literacy is defined as ‘the ability to perform basic reading and 
numerical tasks required to function in the healthcare envi-
ronment’.8 9 A clear theme regarding web-based tools that 
have been user-tested by low health literacy populations is 
that they are helpful (improve knowledge and reduce deci-
sional conflict), but improvements are needed to resolve 
navigation issues and make them easier to use.10–15 Devel-
opers tend to see the opportunity to use online platforms 
to provide more information than they otherwise would on 
paper versions, but this increases the cognitive load, partic-
ularly for individuals unfamiliar with medical jargon.11 12 
Evidence also exists that vulnerable populations may need 
assistance when using web-based applications.16 Fine-tuning 
the information elements and layout of these web-based 
tools to provide simplicity are frequently suggested alter-
ations by low health literacy users regardless of health topic.
In the case of web-based PSA screening tools, it is clear 
that the majority available to the public have not been user-
tested or tested with men of low health literacy – a patient 
population that is in need of access to evidence-based infor-
mation regarding the screening test. We searched for, and 
found, only one web-based PSA screening tool that has been 
user-tested. It was designed for men with a family history of 
prostate cancer who provided positive feedback related to 
navigation, the amount of information and time required to 
complete the decision aid.17 However, this tool was custom-
ised for a certain segment of the male population and did 
not take into account the experience of men with lower 
levels of health literacy. Our study fills this gap by user-testing 
a web-based interactive tool known as Option Grid patient 
decision aids, with men of various education and health 
literacy backgrounds.
The aim of our study is to user-test the ‘PSA test: yes or no?’ 
web-based, interactive Option Grid patient decision aid to 
determine its usability, acceptability and feasibility with men 
of higher and lower health literacy.
MEthODs
Design
A semi-structured interview study was designed and reported 
according to the Consolidated criteria for Reporting Qual-
itative research checklist using purposive sampling, with 
embedded think-aloud methods to evaluate the user expe-
rience with the ‘PSA test: yes or no?’ interactive Option 
Grid decision aid. The think-aloud technique (see data 
collection section) was employed to examine the activities 
and comments of the user and get feedback on the usability 
and feasibility of the tool. Semi-structured interviews were 
conducted following users’ completion of the web-based 
Option Grid to get a better understanding of how to improve 
the interactive version.
recruitment
We posted advertisements at bus stops throughout the 
Upper Valley region describing the study in order to 
invite men to use the PSA Option Grid and provide feed-
back. Also, coordinators at community centres and senior 
centres in the Upper Valley granted us permission to 
post advertisements at their centres. The advertisements 
encouraged men who were interested in participating 
to contact PS to agree on an interview time. The adver-
tisement included information that participants would 
receive a $20 gas card for their participation.
settings
Interviews were conducted at three locations in the 
Upper Valley of New Hampshire and Vermont: (i) the 
Dartmouth-Hitchcock Medical Centre, (ii) Dartmouth 
College library and (iii) the Upper Valley Senior Centre 
in Lebanon, New Hampshire.
Participants
Individuals over 45 years of age living in the Upper Valley 
of New Hampshire and Vermont with no history of pros-
tate cancer, who voluntarily contacted study authors 
via phone or email, and indicated their willingness to 
participate, were eligible for inclusion. Participants were 
excluded if they could not read English. Participants were 
not excluded if they underwent a PSA test at any point 
prior to their participation in the study. Study aims and 
procedures were explained to the participants using an 
information sheet. Participants were informed, prior 
to their consent, that any information provided for the 
study would be kept confidential and stored securely with 
restricted access, thereby minimising risks to the privacy 
of those involved in the study.
Patient and public involvement
The development of the research question, study design 
and procedure are employed to improve the patient 
experience using a web-based patient decision aid like 
Option Grid. Patients were not involved in designing or 
conducting the study. Results were not disseminated to 
study participants.
Development of the PsA option grid decision aid
Option Grid patient decision aids are available in both a 
paper-based and web-based, interactive version and provide 
brief, evidence-based information on the available treat-
ment options for various health conditions or screening 
tests, including the PSA.18 An editorial team comprised 
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of researchers and physicians, and led by GE, developed 
the web-based, interactive PSA Option Grid based on the 
International Patient Decision Aid Standards. The team, 
in consultation with patients, determined the frequently 
asked questions (FAQs). Evidence-based answers to those 
FAQs were provided by conducting a literature review. The 
search focused on systematic review papers to determine 
the risk information embedded in the tool. A document 
listing the references used to formulate the answers for 
each FAQ accompanies the interactive PSA Option Grid. 
Users have the option of printing a paper-based version 
of the tool or using the interactive, web-based version of 
the PSA Option Grid. Printed Option Grid decision aids 
use a tabular format to identify the available treatment 
options for a chosen healthcare topic (columns) and the 
questions that patients most frequently ask (rows).18 The 
content embedded in the tool consists of the evidence-
based answers to the FAQs.19
Users who select the interactive version are asked to 
provide demographical information such as their role 
(patient/patient caregiver or healthcare professional), 
race, age group, gender, ethnicity and geographical 
region. Users are asked: ‘Do you already have a preferred 
option in mind?’ Users can select one of three options: 
having a PSA test, not having a PSA test or not sure. They 
are then asked how strong their preference is – weak, 
moderate or strong. Next, users fill out a four-item, vali-
dated SURE (Sure of myself; Understand information; 
Risk-benefit ratio; Encouragement) survey which helps 
measure their level of decisional conflict,20 21 followed by 
a series of five questions to check their knowledge of the 
PSA test. A series of 10 FAQs are then presented, always 
in the same order. Users select their preference leaning 
based on the answer given for each treatment option. 
They then identify, on a scale of 0 (not important at all) 
to 5 (extremely important), the importance of the infor-
mation presented. Once all 10 steps are completed, the 
user indicates their final preference, identifies their pref-
erence strength based on the scale and completes the 
SURE survey and knowledge questions. Finally, the user 
is presented with a summary of the choices they make for 
each FAQ.
Data collection
All interview sessions were conducted face-to-face with 
the participant and occurred in a private room at one 
of the three study settings. The Chew et al health literacy 
measure was completed by all participants.9 It is a vali-
dated three-item measure that uses a Likert scale (always, 
often, sometimes, occasionally, never) to determine the 
confidence with which individuals fill out forms and 
medical forms independent of any help, and how often 
they require help reading hospital materials.22 The study 
author queried each participant on their highest level of 
education attained. For the purposes of this study, partic-
ipants who did not graduate with a college degree were 
considered to be of lower educational attainment. 
Participants were provided with a laptop. Participants 
in this study were not provided the option to view or print 
the paper-based version of the PSA Option Grid. The 
interactive PSA Option Grid webpage was open, so partic-
ipants could begin the interactive journey when ready. 
As participants were using the interactive tool they were 
asked to verbalise their thoughts - a technique known as 
think-aloud. Think-aloud was used because it enabled us 
to have a better understanding of the usability, feasibility 
and the impact on user ‘cognition and emotion’.23 24 It 
provided participants with the opportunity to voice their 
satisfaction or dissatisfaction with various elements of the 
interactive Option Grid, recommend changes and iden-
tify any difficulties related to navigation or understanding.
Following the completion of the interactive PSA tool, 
we conducted semi-structured interviews (interview guide 
can be viewed in online supplementary appendix 1). 
Questions (derived from Morville’s framework – see anal-
ysis section) were focused on five elements: (1) usability 
(including design and navigation), (2) usefulness 
(including questions on content), (3) desirability (posi-
tive or negative features), (4) value and (5) credibility. 
Interviews were audio-recorded and duration of the inter-
views was noted. Data was collected until saturation was 
achieved – sampling more data would not have led to new 
information regarding usability of the tool as users kept 
repeating the same concerns or ideas. Transcripts were 
not returned to participants for comment or correction.
Analysis
We searched for, but could not find, a validated frame-
work to user-test a web-based patient decision aid. This is 
a relatively new field, and although there does not seem 
to be a well-used or recognised framework, we opted to 
use Morville’s ‘honeycomb’ framework to provide struc-
ture to our data (see figure 1).25 It has been used in the 
past to test oral health education applications, mobile 
device applications, business process management tools 
and social software.26–29 This framework has also been 
employed once before to user-test a decision aid known 
as the ‘decision-box’, and by the Cochrane Collabora-
tion to test user’s experience with their systematic review 
library.30 31 We applied this framework to analyse our data 
since it contains all the features that we wanted to eval-
uate in our interviews. It was developed to assess seven 
different elements associated with the user’s experience 
with an intervention: usability, usefulness, credibility, 
desirability, value, findability and accessibility.28 Usability 
refers to the ease of use, and the degree of satisfaction 
attained from using the PSA interactive Option Grid. 
Usefulness relates to the value of the tool to the user’s 
knowledge-base or potential decision-making regarding 
the PSA test. Credibility explores the user’s level of trust 
for the evidence-based information embedded in the 
tool. We used the desirability element of the framework 
to examine the type of changes the user recommends 
making to improve the user experience. Value explores 
whether the interactive PSA Option Grid ‘advances the 
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mission’, which in this case, means improving knowl-
edge of the PSA test so a user can make a more informed 
decision, or can have a more efficient conversation with 
their provider in future encounters. For the purpose of 
this study, findability and accessibility were not assessed 
because study authors introduced the interactive PSA 
Option Grid to the user. We did not test the ease with 
which one could find the interactive tool online, or the 
barriers to access. We applied five of the seven (usability, 
usefulness, credibility, desirability, value) ‘honeycombs’ 
to evaluate any issues the user may encounter with the 
PSA interactive Option Grid which may be the basis for 
re-design.
Qualitative data analysis
We employed Wallace et al’s recommendation to use the 
‘sometimes’ response on Chew’s Likert scale as the cut-off 
to determine the number of participants with ‘limited or 
marginal health literacy skills’.32
User-testing sessions were recorded and transcribed by 
PS. The framework analysis method was used to analyse 
and code the data.33 We conducted a deductive thematic 
analysis using Morville’s framework, and the data was 
coded independently by two researchers (PS and JS). We 
used this type of qualitative analysis because the coding 
and theme development were directed by the framework 
which enabled us to best achieve our study objectives. The 
ATLAS. ti software was used to assign codes, generated 
based on the five facets of the framework, to sections of 
participant statements, and additional codes were created 
to group codes together. All codes were reviewed to deter-
mine the themes associated with usability and feasibility 
of the PSA interactive Option Grid. We also highlighted 
specific changes or alterations suggested by the partici-
pant to improve the tool.
rEsults
Twenty interviews were conducted with men in the 
Upper Valley region. Ten participants interviewed had 
not completed a college degree (low educational attain-
ment) and 10 participants completed at least one college 
degree (high educational attainment). Of the 10 partici-
pants in the low educational attainment group, eight had 
low health literacy skills. All participants who achieved a 
college degree had high health literacy. All participants 
were white and their ages ranged from 49 to 81. See 
table 1 for details.
thematic analysis
We identified four key themes: (1) Perceived usability was 
contingent on familiarity with digital interfaces (and on 
health literacy), (2) Desire for revisions to improve user 
experience, (3) The value of communicating risks and 
tailoring content to individual attributes like age and 
family history and (4) Credible source of information, useful 
for pre-visit use. See table 2 for themes and sub-themes.
theme 1: perceived usability was contingent on familiarity 
with digital interfaces (and on health literacy)
According to Morville’s framework, usability encompasses 
the ease of use, and the degree of satisfaction attained 
Table 1 Participant characteristics
User Age Ethnicity
Education 
level
Health 
literacy level
  1 65 to 70 White Low Low
  2 70 White Low Low
  3 70 to 75 White Low Low
  4 79 White Low Low
  5 76 White Low Low
  6 70 to 75 White Low Low
  7 50 to 55 White Low Low
  8 50 to 55 White High High
  9 49 White High High
  10 66 White High High
  11 45 to 64 White Low High
  12 69 White High High
  13 75 White High High
  14 81 White High High
  15 70 White High High
  16 50 to 55 White Low High
  17 50 to 55 White Low Low
  18 65 to 70 White High High
  19 65 White High High
  20 62 White High High
Figure 1 Morville’s user-experience ‘honeycomb’ 
framework.
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from using the intervention. Throughout their journey, 
participants with lower levels of health literacy (according 
to the Chew health literacy measure) described their diffi-
culty with using and navigating the tool which affected 
their level of satisfaction with the intervention. Partici-
pants with higher health literacy levels used the tool with 
ease but envisioned potential challenges for men with 
lower levels of education.
Six of the eight users who had lower levels of health 
literacy and low educational attainment were unable to 
use or navigate the PSA interactive Option Grid due to 
their stated unfamiliarity with the computer interface. 
The interviewer (PS) had to read and select the various 
options for the participant. Using an electronic device 
proved to be an intimidating factor in their user-testing 
experience and decreased satisfaction:
I’m not computer literate. That’s obvious…I’m intim-
idated by computers to be honest. (Participant 2 – age 
70, low educational attainment and health literacy)
I don’t like this. You go ahead and use it. (Participant 
3 - age 70 to 75, low educational attainment and 
health literacy)
According to multiple users, the majority of the popula-
tion at the senior centre would not be computer literate. 
We were advised to simplify the tool for a lower health 
literacy population:
I’d say about 40% of the people that come here are 
computer literate. But, for older people that aren’t, 
and I’m thinking about people that come here…you 
need a more simplified version. (Participant 5 – age 
76, low educational attainment and health literacy)
The men with higher health literacy, who were also part 
of the high-education bracket, had no issues with using or 
navigating the tool, but did express their concern for men 
who lack a higher level of education. They could envision 
how this interactive tool may not be usable for those men 
and hypothesised that a coach would be needed to guide 
them through the tool.
I think they [participants with low educational attain-
ment] would need a coach to do this. (Participant 
19 - age 65, high educational attainment and high 
health literacy)
Lastly, twelve users recommended we increase the size 
of the words to make the content easier to read for all 
users. Regardless of health literacy levels, elderly men 
being the target population of the PSA Option Grid have 
specific needs in terms of usability:
The font needs to be bigger. Particularly for people 
like me who may have vision problems… everything 
needs to be bigger. (Participant 3 - age 70 to 75, low 
educational attainment and health literacy)
Table 2 Themes and sub-themes derived from user-testing data
Themes Sub-themes
Perceived usability was 
contingent on familiarity with 
digital interfaces (and on 
health literacy).
 ► Participants with low health literacy have difficulty using computers.
 ► A solution to alleviate computer intimidation is to provide low health literacy users with a 
paper-based decision aid.
 ► Participants with high health literacy skills recognised that navigating the PSA Option Grid 
could be challenging for participants with low health literacy, so they suggested having a 
coach accompany them through the tool.
 ► Increase the size of the words throughout the interactive Option Grid.
Desire for revisions to improve 
user experience.
 ► The layout of the FAQ pages need to be changed. Preferably stating a fact about the PSA 
test, and then asking: are you more or less inclined to have the PSA test? Based on that 
fact.
 ► Embed the data viewer icon array on the FAQ page, so the user does not have to click on an 
option to view the pictorial.
 ► Remove the importance ratings at the bottom of each FAQ page.
The value of communicating 
risks and tailoring content to 
individual attributes like age 
and family history.
 ► Men desire a comprehensive source of information, and appreciate the risk information 
embedded in the tool.
 ► Participants believed that the PSA Option Grid is an ideal foundation for a more 
collaborative discussion with their physician.
 ► Users would prefer to see age—specific information, and information related to family 
history and its impact on prostate cancer risk.
Credible source of 
information, useful for pre-visit 
use.
 ► Completing the interactive PSA Option Grid is not burdensome.
 ► It is best to complete the tool prior to the clinical encounter and bring the results to the 
physician to have a discussion.
 ► The PSA Option Grid represents a credible source of knowledge that can be used by men to 
be more involved in their healthcare decision making.
FAQ, frequently asked question; PSA, prostate-specific antigen. 
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The discrepancy between men with higher and lower 
health literacy levels regarding usability was evident and 
is a factor in the ability to use and navigate the PSA inter-
active Option Grid.
theme 2: desire for revisions to improve user experience
The desirability component of the framework highlights 
the desire to change various attributes of the tool to 
improve the user experience. What type of changes do 
users want to see? We describe these changes in detail.
Participants had some difficulty understanding the 
actions they needed to take when faced with the FAQ 
portion of the interactive tool. For instance, the first FAQ 
poses the question: what does the test involve? The having 
a PSA test option states that the PSA is a blood test that 
measures the antigen level in the blood from the prostate 
gland, and the not having a PSA test option simply states 
‘does not apply.’ For the second FAQ, the same informa-
tion was associated with each option – ‘15% of American 
men will develop prostate cancer in their lifetime’. Eight 
participants felt like the information associated with 
each option were unclear, leading to confusion on which 
screening option they should choose.
So, I’m confused as to why I have to check this box as 
opposed to this box because they both have the same 
information. What are you trying to tease out here 
in this question with the two choices? (Participant 
12 - age 69, high educational attainment and health 
literacy)
To alleviate confusion, users suggested we alter the 
organisation of the material for each FAQ. Participants 
indicated we should state a fact related to the PSA test, 
and then ask: does this information make you more or 
less inclined to have, or not have, a PSA test? Then, the 
participant can check the box based on their preference. 
This adjustment would also decrease the amount of mate-
rial embedded in each FAQ page.
Start out with this bit of information up here, and 
then that’s when you get the two options. Put the 
statement you just made, and then add…does this in-
formation make you more or less inclined to have the 
test or not? (Participant 10 - age 66, high educational 
attainment and health literacy)
I’m suggesting that you have the piece of informa-
tion, and then you’re given two boxes, yes/no, click 
one. (Participant 12 - age 69, high educational attain-
ment and health literacy)
I would be more…it would seem a little more logical 
to me to have a number of those facts laid out, and 
then say: do these make you feel more or less likely 
to want to have a PSA? (Participant 18 - age 65 to 70, 
high educational attainment and health literacy)
For some FAQs, the having a PSA test option provided 
risk information. Below that risk information was a ‘data 
viewer’ option that, if clicked, provided users with an icon 
array to help them better understand the frequencies or 
percentages presented (see figure 2). Only two partic-
ipants in the sample recognised the data viewer due to 
its small presence on the page. Once we directed their 
attention to the icon array, users indicated that it should 
be embedded with the rest of the information:
Yeah, pictorials are good. I didn’t have problems with 
the 15%, but I would incorporate this (the icon ar-
ray) in here (on the FAQ page). (Participant 15 - age 
70, high educational attainment and health literacy)
The third recommended adjustment was the removal 
of the importance ratings at the bottom of each FAQ. 
The majority of users did not understand the purpose or 
usefulness of that exercise, considering their attention 
was focused mainly on the information. The information 
was generally considered to always be of high importance 
to the user:
So, to me the importance ratings of each question 
were less important than the stuff above. I thought 
the top part was informative, and then the zero to five 
scale was informative to you, the researcher, but not 
to me. (Participant 8 - age 50 to 55, high educational 
attainment and health literacy)
Ultimately, users suggested to re-organise the material 
for each FAQ by stating a piece of information, and then 
Figure 2 Icon array embedded in the ‘data viewer’ option 
in the PSA interactive Option Grid. PSA, prostate-specific 
antigen. 
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asking whether or not that information made the user 
more or less inclined to have the PSA test, thus clarifying 
the action required. Moving the icon array embedded in 
the data viewer to accompany the information for each 
FAQ would also help users visualise and understand the 
percentages and frequencies presented.
theme 3: the value of communicating risks and tailoring 
content to individual attributes like age and family history
Value, according to the framework, refers to the attri-
butes that participants deem most valuable. Viewing the 
tool through this lens, we identified that the risk informa-
tion was most valued. In particular, users wanted to see 
prostate cancer risk information related to age and family 
history.
Participants felt that the greatest asset of the PSA inter-
active Option Grid was the level of high-quality, evidence-
based information. It was also easy to understand, and 
much of the numerical information was new to users:
There were a couple of things that I wasn’t aware of 
regarding the PSA test, which came up in here. About 
30% of men with a high PSA have prostate cancer. I 
didn’t know that. (Participant 2 – age 70, low educa-
tional attainment and health literacy)
Even for participants who already possessed knowledge 
of the risks and benefits associated with the PSA test, they 
felt that the tool provided the foundation for a discussion 
with a physician:
I think this is a good introduction because you have 
people out here who haven’t considered or wor-
ried about it, and need to be educated. They need 
to be brought up to speed… as an introduction this 
will work. You may have had some people today that 
didn’t know what the heck they were doing or haven’t 
really paid attention… (Participant 3 - age 70 to 75, 
low educational attainment and health literacy)
In particular, participants highlighted the value of 
the various probabilities associated with the PSA test, 
including: likelihood of developing prostate cancer in 
one’s lifetime, the chances of getting prostate cancer if 
the PSA test is high or normal, the percentage of prostate 
cancers that are aggressive and the risks associated with 
prostate biopsies and cancer treatments.
The immediate risk of the various procedures, or if 
you had a high PSA, the risk associated with having 
a biopsy. That was the most helpful piece of informa-
tion for me. (Participant 9 - age 49, high educational 
attainment and health literacy)
Despite the participants’ satisfaction with the true 
content in the tool, they indicated that there were two 
key information elements missing. The first is age-specific 
risk information related to prostate cancer. Stratifying the 
risk information according to age would help men better 
understand when the ideal time is to consider the PSA 
test. Second, how does family history influence one’s risk 
of prostate cancer? How important is family history for 
those considering the PSA test? These are questions that 
participants felt should be addressed in order to create a 
more comprehensive tool for users.
I think it would be interesting to know something 
about age because I’ve been told, I heard, that if you 
are over a certain age, the speed at which the average 
prostate cancer moves is very slow that you’ll proba-
bly die of something else first. (Participant 13 – age 
75, high educational attainment and health literacy)
theme 4: credible source of information, useful for pre-visit 
use
According to the framework, credibility refers to the trust 
given to the tool’s contents. It is because of the trust in 
the evidence-based nature of the PSA Option Grid that 
participants found the tool useful. The intervention 
was useful in expanding the user’s knowledge-base and 
helped him make a decision regarding the PSA test. The 
two mechanisms of the framework are linked in the sense 
that the tool represented a credible source of informa-
tion for users, and it could be used in a clinical setting 
prior to their discussion with the physician.
Participants felt that the ideal time to complete the 
tool would be prior to the clinical encounter due to the 
time pressures physicians experience. The patient can 
then bring the summary of their results to the physician 
to facilitate a better discussion about whether or not the 
PSA test is worthwhile.
Yes. I think people could fill this thing out before the 
visit, so that they don’t have to sit with the doctor and 
hash through it. (Participant 8 - age 50 to 55, high 
educational attainment and health literacy)
Participants recognised that physicians have limited 
time with their patients, but the need to have a more 
constructive discussion about the PSA test still exists. 
They believed that the interactive PSA Option Grid 
represented the basis for an improved interaction with 
the provider because it was a credible source of infor-
mation. There is a plethora of resources available in 
print or online regarding the PSA test, but men indi-
cated their difficulty deciphering which information 
is credible and which information is not. All partic-
ipants felt that being provided with one source that 
can provide accurate facts can be helpful to men in 
their decision-making, alleviating concerns of getting 
misinformation.
Everyone Google’s…all the time, and so, more and 
more people, are going to their physician with ques-
tions they found online…I feel like a tool like this 
if presented within the context of a healthy conver-
sation with your physician is valuable. (Participant 
9 - age 49, high educational attainment and health 
literacy)
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DIsCussIOn
Overall, men indicated that the interactive PSA Option 
Grid was useful despite the challenges some faced engaging 
with the tool, the information acceptable with an emphasis 
to add more risk information associated with age and 
family history and potentially feasible to implement this 
tool prior to a clinical consultation. The usability issues 
for participants with low health literacy can perhaps be 
attributed to an interactive tool that was not designed 
for such a vulnerable population. It is worth noting that 
many men with lower health literacy also seemed unfa-
miliar with computers and reluctant to use the online 
intervention independently. The difficulty experienced 
in navigating the digital interface, feelings of intimidation 
with having to use a laptop, preference for a paper-based 
version and desire for changes to the layout and presen-
tation of information all suggested that the PSA Option 
Grid had not paid enough attention to usability. The risk 
information provided by the Option Grid was found to be 
highly valuable with most hoping to see content tailored 
to their specific attributes like age and family history in 
a future version of the tool. The PSA Option Grid also 
represented a credible source of information, and users 
envisioned using this tool prior to the clinical encounter 
to facilitate an improved discussion with their physician.
The strength of this study was the use of the think-
aloud technique in conjunction with in-depth interviews 
to examine the usability, acceptability and feasibility of 
the tool. The purposive sampling method enabled us to 
include participants across the health literacy spectrum, 
including those with lower levels of health literacy and 
education who are not computer-savvy. Due to two study 
authors’ (GE and M-AD) involvement in developing the 
PSA interactive Option Grid, PS conducted the inter-
views and analysis of the data to mitigate the risk of bias. 
A weakness of our study is the fact that we did not use 
a validated framework to user-test patient decision aids. 
Also, we did not provide the option for participants to use 
a tablet or smartphone to access the PSA Option Grid. It 
may be that using these devices could have changed some 
of our results. We also recognise that interviewing a more 
heterogenous sample that includes men of different 
ethnicities and from different locations from across the 
USA would have provided us with a different user-testing 
perspective and made our results more applicable to deci-
sion aid developers across cultural contexts.
Our research highlights the importance of user-testing 
interactive decision aids prior to making it available to 
the online world. Developing a decision aid that is usable 
by men with lower health literacy involves an iterative 
interview process as described by Barton et al in their 
development of an encounter-based decision support 
intervention for rheumatoid arthritis medications.34 
Patients were interviewed on two separate occasions in 
order to refine the tool prior to pilot testing.34 The devel-
opers of the PSA Option Grid did not user-test prior to 
its publication and based on this study we know men with 
lower health literacy struggled to navigate the application. 
Using a laptop proved to be a challenging exercise that 
provoked feelings of intimidation - an unprecedented 
finding that adds a layer of complexity for developers of 
interactive tools. The design changes recommended by 
users also suggests a desire for simplicity by embedding 
one fact about the PSA per FAQ to assess preference. 
Developers of decision aids should user-test their tools to 
ensure the layout and presentation of information meets 
the needs of low health literacy patients, and so that they 
can navigate the tool without assistance.
Our study indicates that men value risk information 
regarding the PSA test, and seek information tailored 
to their own characteristics, particularly age and family 
history. Survey and qualitative research echo these find-
ings.35 36 Despite information needs being highly variable 
and dependent on demographics, the desire for risk 
information remained stable for men making a deci-
sion on whether to have the PSA test or not.35 Davison 
et al concluded that ‘men who had sons, a positive family 
history and lower levels of education ranked hereditary 
risk’ as a key component in their prostate screening 
decision-making process.37 Family history was repeatedly 
mentioned by participants in our sample as a factor that 
weighs heavily on the decision-making process. Although 
sexual function was not an issue raised by participants 
in our study, research shows that the potential effects of 
prostate screening on sexual function is significant to 
younger men considering the PSA test.38 39 In particular, 
participants with higher education consider sexual func-
tion to be of value when reflecting on the test.39
The source of the various facets of information 
regarding the PSA test is also a major theme in the liter-
ature. The internet has become the prime resource for 
men seeking credible information on the PSA test.40 The 
preferred sites are those that are recognised or ‘institu-
tions with established reputations’.41 Also, men often 
resort to online patient discussion forums for informa-
tion support – a platform that was not mentioned by 
participants in our sample.42 43
Participants felt that it would be feasible to use the tool 
prior to the consultation with the physician. According 
to the Ottawa Inventory of patient decision aids, there 
are eight PSA tools available for men – three of which 
are designed for use in the encounter. The feasibility or 
routine implementation of these decision aids has yet to 
be studied. Future work should examine how and when 
to best integrate these online decision support tools that 
have shown to increase patient knowledge and satisfac-
tion related to the prostate cancer screening decision.44 
In addition, the community of decision aid developers 
should set an agenda to explore how to make web-based 
tools accessible and usable for low literacy individuals.
COnClusIOn
The PSA interactive Option Grid decision aid was useful 
but not optimally designed to ensure usability for all men 
in the sample. Research is needed to determine how 
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best to increase access to patient decision aids (and the 
information embedded in these tools) so individuals of 
all literacy, health literacy and computer literacy levels 
can benefit. The value of the evidence-based risk infor-
mation embedded in the tool rendered it credible and 
acceptable by users who wish to see information associ-
ated with family history and age in a future version of the 
PSA Option Grid. Users envisioned the tool being feasibly 
implemented prior to their visit with the physician. 
Overall, this highlights the importance of user-testing 
web-based decision aids prior to their release in order to 
get a comprehensive understanding of user needs and 
priorities. Based on our results, decision aid developers 
can ascertain that users prefer simplicity regarding the 
layout and presentation of evidence-based information 
and prefer to view risk data that is based on their personal 
attributes (ie, age and family history). However, more 
research is needed to better understand how interactive, 
web-based decision aids can be better designed to be 
usable by individuals across the health literacy spectrum.
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